Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Enhancing Tregs can protect against alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Targeting Vδ1+T-cells may help treat alopecia areata.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

The role of γδT-cells in causing alopecia areata remains unclear.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Special cells can help regrow hair in alopecia areata.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.